HSC-induced N-methyltransferase (NNMT) promotes HCC cell invasion and tumor metastasis by enhancing the expression of CD44v3, making it a promising prognostic biomarker and therapeutic target for HCC (91). This evidence concerns the gene NNMT and hepatocellular carcinoma.